| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Gefitinib | GDSC1000 | pan-cancer | AAC | 0.094 | 0.006 |
| mRNA | YM201636 | GDSC1000 | pan-cancer | AAC | -0.089 | 0.006 |
| mRNA | nintedanib | CTRPv2 | pan-cancer | AAC | -0.1 | 0.007 |
| mRNA | TPCA-1 | CTRPv2 | pan-cancer | AAC | 0.089 | 0.007 |
| mRNA | Bleomycin | GDSC1000 | pan-cancer | AAC | 0.1 | 0.007 |
| mRNA | 17-AAG | GDSC1000 | pan-cancer | AAC | 0.09 | 0.007 |
| mRNA | SJ-172550 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.008 |
| mRNA | JQ-1 | CTRPv2 | pan-cancer | AAC | -0.086 | 0.008 |
| mRNA | Sorafenib | GDSC1000 | pan-cancer | AAC | -0.15 | 0.008 |
| mRNA | momelotinib | CTRPv2 | pan-cancer | AAC | 0.093 | 0.008 |